Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: A case report

Cases Journal

Volumn 2, Issue 8, 2009, Pages

  Anastasiadis, Athanasios ^a   Margaritis, Dimitrios ^a   Kotsianidis, Ioannis ^a   Spanoudakis, Emmanouil ^a   Christoforidou, Anna ^a   Kostopoulos, Ioannis ^b   Tsatalas, Constantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; GLUCOSE; RITUXIMAB;

AGED; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTOSIS; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LEUKOPENIA; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NIGHT SWEAT; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLOR; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PURE RED CELL ANEMIA; RETICULOCYTE COUNT; SPLENECTOMY; SPLENIC MARGINAL ZONE LYMPHOMA; SPLENOMEGALY; TREATMENT RESPONSE;

EID: 77953404463     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-6913     Document Type: Article

References (14)

1. Erslev AJ: Pure red cell aplasia. In Williams Hematology. 6th edition. Edited by Beutler E, Coller BS, Lichtman MA, Kipps TJ, Selgsohn U. New York: McGraw-Hill Medical Publishing Division; 2001:391-398.
2. Gordon-Smith EC, Marsh J: Pure red cell aplasia. In Postgraduate Haematology. 5th edition. Edited by Hoffbrand AV, Catovsky D, Tuddenham D. Oxford: Blackwell Publishing; 2005:201-202.
3. Casadevall N, Cournoyer D, Marsh J, Messner H, Pallister C, Parker-Williams J, Rossert J: Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia. Eur J Haematol 2004, 73:389-396.
4. Fisch P, Handgretinger R, Schaefer HE: Pure red cell aplasia. Br J Haematol 2000, 111:1010-1022.
5. Djaldetti M, Blay A, Bergman M, Salman H, Bessler H: Pure red cell aplasia-a rare disease with multiple causes. Biomed Pharmacother 2003, 57:326-332.
6. Jaffe ES, Harris NL, Stein H, Vardiman JW: WHO classification of tumors: Pathology and genetics of tumors of haematopoetic and lymphoid tissues. IARC Press: Lyon, 2001:135-137.
7. Narra K, Borghaei H, Al-Saleem T, Höglund M, Smith MR: Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: Report of two cases and review of the literature. Leuk Res 2006, 30:109-114.
8. Zeidman A, Fradin Z, Barac Y, Bendayan D, Mittelman M, Orlin J: Splenic lymphoma presenting as Warm Autoimmune Hemolytic Anemia associated with Pure Red Cell Aplasia. Vox Sang 2000, 78:126-129.
9. Bennett M, Sharma K, Yegena S, Gavish I, Dave HP, Schechter G: Rituximab monotherapy for splenic marginal zone lymphoma. Haematologica 2005, 90:856-858.
10. Tsimberidou AM, Catovsky D, Schlette E, O'Brien S, Wierda WG, Kantarjian H, Garcia-Manero G, Wen S, Do KA, Lerner S, Keating MJ: Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer 2006, 107:125-135.
11. Kalpadakis C, Pangalis GA, Dimopoulou MN, Vassilakopoulos TP, Kyrtsonis MC, Korkolopoulou P, Kontopidou FN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Tsaftaridis P, Plata E, Angelopoulou MK: Rituximab monotherapy is highly effective in splenic marginal zome lymphoma. Hematol Oncol 2007, 25:127-131.
12. Sawada K, Fujishima N, Hirokawa M: Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 2008, 142:505-514.
13. D'Arena G, Vigliotti ML, Dell'Olio M, Villa MR, Mantuano S, Scalzulli PR, La Sala A, Abbadessa A, Mastrullo L, Cascavilla N: Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia. Eur J Haematol 2008, 82:235-239.
14. Pantelidou D, Tsatalas C, Margaritis D, Kaloutsi V, Spanoudakis E, Bourikas G: Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukaemia-associated pure red cell aplasia. Hematol J 2004, 5:546-547.